Who Owns COEP?

Coeptis Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$16.62

+0.15 (+0.93%)

Market Cap

$44.7M

Shares Outstanding

3,513,840

Institutional Holders

9

Total Inst. Value

$515K

% of Float Held

QoQ Holder Change

-6

Institutional data as of Q1 2025

New Positions

4

Closed Positions

2

Increased

2

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INCNew$228K24,437
2GEODE CAPITAL MANAGEMENT, LLCNew$186K19,969
3UBS Group AG$81K8,635
4Steward Partners Investment Advisory, LLC$9K1,000
5Tower Research Capital LLC (TRC)$6K675
6OSAIC HOLDINGS, INC.New$5K500
7Semmax Financial Advisors Inc.New$625
8BARCLAYS PLC$03
9BANK OF AMERICA CORP /DE/$018

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
BARCLAYS PLC-64$0
Tower Research Capital LLC (TRC)-48$6K

Related Stocks

Frequently Asked Questions

How many institutional investors hold COEP?

As of Q1 2025, 9 institutional investors report holding COEP (Coeptis Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most COEP?

The largest institutional holder of COEP is VANGUARD GROUP INC with $228K in shares.

Are institutions buying or selling COEP?

This quarter, 4 institutions opened new positions in COEP and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.